These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 1627634

  • 1. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W, Infante J, Wang SR, Infante R.
    Biochim Biophys Acta; 1992 Jul 09; 1127(1):57-66. PubMed ID: 1627634
    [Abstract] [Full Text] [Related]

  • 2. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
    Hidaka Y, Hotta H, Nagata Y, Iwasawa Y, Horie M, Kamei T.
    J Biol Chem; 1991 Jul 15; 266(20):13171-7. PubMed ID: 1649182
    [Abstract] [Full Text] [Related]

  • 3. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH, van Vliet A, Roodenburg L, Jansen LM, Griffioen M.
    Biochem Pharmacol; 1993 Jun 09; 45(11):2203-8. PubMed ID: 8517861
    [Abstract] [Full Text] [Related]

  • 4. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y, Hidaka Y, Ishida F, Kamei T.
    Biochem Pharmacol; 1990 Aug 15; 40(4):843-50. PubMed ID: 2167097
    [Abstract] [Full Text] [Related]

  • 5. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA, Simon HM, Patel DD, Bentzen C, Niesor E, Jackson B, Suckling KE.
    J Biol Chem; 1996 Jun 14; 271(24):14376-82. PubMed ID: 8662919
    [Abstract] [Full Text] [Related]

  • 6. Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
    Clerc T, Sbarra V, Domingo N, Rault JP, Diaconescu N, Moutardier V, Hasselot N, Lafont H, Jadot G, Laruelle C, Chanussot F.
    Br J Pharmacol; 1996 Aug 14; 118(7):1862-8. PubMed ID: 8842455
    [Abstract] [Full Text] [Related]

  • 7. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
    Cohen LH, Griffioen M.
    Biochem J; 1988 Oct 01; 255(1):61-7. PubMed ID: 2848511
    [Abstract] [Full Text] [Related]

  • 8. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A, Griffioen M, Cohen LH.
    Biochem J; 1987 Jan 15; 241(2):345-51. PubMed ID: 3036060
    [Abstract] [Full Text] [Related]

  • 9. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y.
    J Atheroscler Thromb; 2000 Jan 15; 7(3):138-44. PubMed ID: 11480454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM, Swinney DC, Heller R, Dunlap B, Chiou M, Malonzo E, Haller J, Walker KA, Salari A, Murakami S.
    Biochem Pharmacol; 1995 Aug 08; 50(4):529-44. PubMed ID: 7646560
    [Abstract] [Full Text] [Related]

  • 15. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
    Le Jossic-Corcos C, Duclos S, Ramirez LC, Zaghini I, Chevillard G, Martin P, Pineau T, Bournot P.
    Biochim Biophys Acta; 2004 Jul 05; 1683(1-3):49-58. PubMed ID: 15238219
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
    Kocarek TA, Reddy AB.
    Drug Metab Dispos; 1996 Nov 05; 24(11):1197-204. PubMed ID: 8937853
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of gemfibrozil and clofibric acid on peroxisomal enzymes and cholesterol synthesis of rat hepatocytes.
    Hashimoto F, Taira S, Hayashi H.
    Biol Pharm Bull; 1998 Nov 05; 21(11):1142-7. PubMed ID: 9853402
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
    Scharnagl H, Schliack M, Löser R, Nauck M, Gierens H, Jeck N, Wieland H, Gross W, März W.
    Atherosclerosis; 2000 Nov 05; 153(1):69-80. PubMed ID: 11058701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.